Abstract
Atherosclerosis (AS) is characterized by impairment and apoptosis of endothelial cells, continuous systemic and focal inflammation and dysfunction of vascular smooth muscle cells, which is documented as the traditional cellular paradigm. However, the mechanisms appear much more complicated than we thought since a bulk of studies on efferocytosis, transdifferentiation and novel cell death forms such as ferroptosis, pyroptosis, and extracellular trap were reported. Discovery of novel pathological cellular landscapes provides a large number of therapeutic targets. On the other side, the unsatisfactory therapeutic effects of current treatment with lipid-lowering drugs as the cornerstone also restricts the efforts to reduce global AS burden. Stem cell- or nanoparticle-based strategies spurred a lot of attention due to the attractive therapeutic effects and minimized adverse effects. Given the complexity of pathological changes of AS, attempts to develop an almighty medicine based on single mechanisms could be theoretically challenging. In this review, the top stories in the cellular landscapes during the initiation and progression of AS and the therapies were summarized in an integrated perspective to facilitate efforts to develop a multi-targets strategy and fill the gap between mechanism research and clinical translation. The future challenges and improvements were also discussed.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature, 2011,473(7347):317–325
Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol, 2011,12(3):204–212
Fan J, Watanabe T. Atherosclerosis: Known and unknown. Pathol Int, 2022,72(3):151–160
Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol, 2006,47(8 Suppl):C7–12
Duan H, Zhang Q, Liu J, et al. Suppression of apoptosis in vascular endothelial cell, the promising way for natural medicines to treat atherosclerosis. Pharmacol Res, 2021,168:105599
Wolf D, Ley K. Immunity and Inflammation in Atherosclerosis. Circ Res, 2019,124(2):315–327
Mozzini C, Garbin U, Fratta Pasini AM, et al. An exploratory look at NETosis in atherosclerosis. Intern Emerg Med, 2017,12(1):13–22
Grootaert MOJ, Moulis M, Roth L, et al. Vascular smooth muscle cell death, autophagy and senescence in atherosclerosis. Cardiovasc Res, 2018,114(4):622–634
Libby P, Buring JE, Badimon L, et al. Atherosclerosis. Nat Rev Dis Primers, 2019,5(1):56
Hu MJ, Tan JS, Jiang WY, et al. The optimal percutaneous coronary intervention strategy for patients with ST-segment elevation myocardial infarction and multivessel disease: a pairwise and network meta-analysis. Ther Adv Chronic Dis, 2022,13:20406223221078088
Chen W, Schilperoort M, Cao Y, et al. Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis. Nat Rev Cardiol, 2022,19(4):228–249
Dai T, He W, Yao C, et al. Applications of inorganic nanoparticles in the diagnosis and therapy of atherosclerosis. Biomater Sci, 2020,8(14):3784–3799
Zhang N, Xie X, Chen H, et al. Stem cell-based therapies for atherosclerosis: perspectives and ongoing controversies. Stem Cells Dev, 2014,23(15):1731–1740
Glass CK and Witztum JL. Atherosclerosis. the road ahead. Cell, 2001,104(4):503–516
Rochette L, Lorin J, Zeller M, et al. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets? Pharmacol Ther, 2013,140(3):239–257
Witztum JL, Lichtman AH. The influence of innate and adaptive immune responses on atherosclerosis. Annu Rev Pathol, 2014,9:73–102
Marzolla V, Armani A, Mammi C, et al. Essential role of ICAM-1 in aldosterone-induced atherosclerosis. Int J Cardiol, 2017,232:233–242
Jia X, Bai X, Yang X, et al. VCAM-1-bmdmg peptide targeted cationic liposomes containing NLRP3 siRNA to modulate LDL transcytosis as a novel therapy for experimental atherosclerosis. Metabolism, 2022,135:155274
Georgakis MK, Bernhagen J, Heitman LH, et al. Targeting the CCL2-CCR2 axis for atheroprotection. Eur Heart J, 2022,43(19):1799–1808
Aiello RJ, Bourassa PA, Lindsey S, et al. Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol, 1999,19(6):1518–1525
Manta CP, Leibing T, Friedrich M, et al. Targeting of Scavenger Receptors Stabilin-1 and Stabilin-2 Ameliorates Atherosclerosis by a Plasma Proteome Switch Mediating Monocyte/Macrophage Suppression. Circulation, 2022,146(23):1783–1799
Thorp E, Subramanian M, Tabas I. The role of macrophages and dendritic cells in the clearance of apoptotic cells in advanced atherosclerosis. Eur J Immunol, 2011,41(9):2515–2518
Myasoedova VA, Chistiakov DA, Grechko AV, et al. Matrix metalloproteinases in pro-atherosclerotic arterial remodeling. J Mol Cell Cardiol, 2018,123:159–167
Saigusa R, Winkels H, Ley K. T cell subsets and functions in atherosclerosis. Nat Rev Cardiol, 2020,17(7):387–401
Bot I, Daissormont IT, Zernecke A, et al. CXCR4 blockade induces atherosclerosis by affecting neutrophil function. J Mol Cell Cardiol, 2014,74:44–52
Hofheinz K, Seibert F, Ackermann JA, et al. Formation of atherosclerotic lesions is independent of eosinophils in male mice. Atherosclerosis, 2020,311:67–72
Zhu J, Liu B, Wang Z, et al. Exosomes from nicotine-stimulated macrophages accelerate atherosclerosis through miR-21-3p/PTEN-mediated VSMC migration and proliferation. Theranostics, 2019,9(23):6901–6919
Monk BA, George SJ. The Effect of Ageing on Vascular Smooth Muscle Cell Behaviour— A Mini-Review. Gerontology, 2015,61(5):416–426
Bentzon JF, Otsuka F, Virmani R, et al. Mechanisms of plaque formation and rupture. Circ Res, 2014,114 (12):1852–1866
Weber C, Badimon L, Mach F, et al. Therapeutic strategies for atherosclerosis and atherothrombosis: Past, present and future. Thromb Haemost, 2017,117(7):1258–1264
Ali AH, Younis N, Abdallah R, et al. Lipid-Lowering Therapies for Atherosclerosis: Statins, Fibrates, Ezetimibe and PCSK9 Monoclonal Antibodies. Curr Med Chem, 2021,28(36):7427–7445
Pasta A, Cremonini AL, Pisciotta L, et al. PCSK9 inhibitors for treating hypercholesterolemia. Expert Opin Pharmacother, 2020,21(3):353–363
Albers JJ, Marcovina SM, Imperatore G, et al. Prevalence and determinants of elevated apolipoprotein B and dense low-density lipoprotein in youths with type 1 and type 2 diabetes. J Clin Endocrinol Metab, 2008,93(3):735–742
Hagensen MK, Mortensen MB, Kjolby M, et al. Increased retention of LDL from type 1 diabetic patients in atherosclerosis-prone areas of the murine arterial wall. Atherosclerosis, 2019,286:156–162
Tabit CE, Shenouda SM, Holbrook M, et al. Protein kinase C-β contributes to impaired endothelial insulin signaling in humans with diabetes mellitus. Circulation, 2013,127(1):86–95
Ridker PM, Everett BM, Thuren T, et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. N Engl J Med, 2017,377(12):1119–1131
Lv N, Zhang Y, Wang L, et al. LncRNA/CircRNA-miRNA-mRNA Axis in Atherosclerotic Inflammation: Research Progress. Curr Pharm Biotechnol, 2023, doi: https://doi.org/10.2174/0113892010267577231005102901
Cahill PA, Redmond EM. Vascular endothelium — Gatekeeper of vessel health. Atherosclerosis, 2016, 248:97–109
Lin X, Ouyang S, Zhi C, et al. Focus on ferroptosis, pyroptosis, apoptosis and autophagy of vascular endothelial cells to the strategic targets for the treatment of atherosclerosis. Arch Biochem Biophys, 2022,715:109098
Wang Y, Fan Y, Song Y, et al. Angiotensin II induces apoptosis of cardiac microvascular endothelial cells via regulating PTP1B/PI3K/Akt pathway. In Vitro Cell Dev Biol Anim, 2019,55(10):801–811
Ouyang S, You J, Zhi C, et al. Ferroptosis: the potential value target in atherosclerosis. Cell Death Dis, 2021,12(8):782
Chen X, Cai Q, Liang R, et al. Copper homeostasis and copper-induced cell death in the pathogenesis of cardiovascular disease and therapeutic strategies. Cell Death Dis, 2023,14(2):105
He B, Nie Q, Wang F, et al. Role of pyroptosis in atherosclerosis and its therapeutic implications. J Cell Physiol, 2021,236(10):7159–7175
Wang H, Liu C, Zhao Y, et al. Mitochondria regulation in ferroptosis. Eur J Cell Biol, 2020,99(1):151058
Stockwell BR, Friedmann Angeli JP, Bayir H, et al. Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease. Cell, 2017, 171(2):273–285
Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol, 2021,22(4):266–282
Yang WS, Kim KJ, Gaschler MM, et al. Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc Natl Acad Sci U S A, 2016,113(34): E4966–75
Doll S, Proneth B, Tyurina YY, et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol, 2017,13(1):91–98
Feng H, Schorpp K, Jin J, et al. Transferrin Receptor Is a Specific Ferroptosis Marker. Cell Rep, 2020,30(10):3411–3423.e7
Doll S, Freitas FP, Shah R, et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature, 2019,575 (7784):693–698
Ma Y, Yi M, Wang W, et al. Oxidative degradation of dihydrofolate reductase increases CD38-mediated ferroptosis susceptibility. Cell Death Dis, 2022,13(11): 944
Kraft VAN, Bezjian CT, Pfeiffer S, et al. GTP Cyclohydrolase 1/Tetrahydrobiopterin Counteract Ferroptosis through Lipid Remodeling. ACS Cent Sci, 2020,6(1):41–53
Wang Y, Zhao Y, Ye T, et al. Ferroptosis Signaling and Regulators in Atherosclerosis. Front Cell Dev Biol, 2021,9:809457
Guo Z, Ran Q, Roberts LJ2nd, et al. Suppression of atherogenesis by overexpression of glutathione peroxidase-4 in apolipoprotein E-deficient mice. Free Radic Biol Med, 2008,44(3):343–352
Chen CJ, Huang HS, Chang WC. Inhibition of arachidonate metabolism in human epidermoid carcinoma a431 cells overexpressing phospholipid hydroperoxide glutathione peroxidase. J Biomed Sci, 2002,9(5):453–459
Gao M, Monian P, Quadri N, et al. Glutaminolysis and Transferrin Regulate Ferroptosis. Mol Cell, 2015,59(2):298–308
Mou Y, Zhang L, Liu Z, et al. Abundant expression of ferroptosis-related SAT1 is related to unfavorable outcome and immune cell infiltration in low-grade glioma. BMC Cancer, 2022,22(1):215
Chu B, Kon N, Chen D, et al. ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway. Nat Cell Biol, 2019,21(5):579–591
Li C, Chen JW, Liu ZH, et al. CTRP5 promotes transcytosis and oxidative modification of low-density lipoprotein and the development of atherosclerosis. Atherosclerosis, 2018,278:197–209
Gao Y, Chen B, Wang R, et al. Knockdown of RRM1 in tumor cells promotes radio-/chemotherapy induced ferroptosis by regulating p53 ubiquitination and p21-GPX4 signaling axis. Cell Death Discov, 2022,8(1):343
Kang R, Kroemer G, Tang D. The tumor suppressor protein p53 and the ferroptosis network. Free Radic Biol Med, 2019,133:162–168
Zhang Q, Liu J, Duan H, et al. Activation of Nrf2/HO-1 signaling: An important molecular mechanism of herbal medicine in the treatment of atherosclerosis via the protection of vascular endothelial cells from oxidative stress. J Adv Res, 2021,34:43–63
Linna-Kuosmanen S, Tomas Bosch V, Moreau PR, et al. NRF2 is a key regulator of endothelial microRNA expression under proatherogenic stimuli. Cardiovasc Res, 2021,117(5):1339–1357
Song X, Long D. Nrf2 and Ferroptosis: A New Research Direction for Neurodegenerative Diseases. Front Neurosci, 2020,14:267
Ruotsalainen AK, Lappalainen JP, Heiskanen E, et al. Nuclear factor E2-related factor 2 deficiency impairs atherosclerotic lesion development but promotes features of plaque instability in hypercholesterolaemic mice. Cardiovasc Res, 2019,115(1):243–254
Kerins MJ, Ooi A. The Roles of NRF2 in Modulating Cellular Iron Homeostasis. Antioxid Redox Signal, 2018,29(17):1756–1773
Murphy AJ, Sarrazy V, Wang N, et al. Deficiency of ATP-binding cassette transporter B6 in megakaryocyte progenitors accelerates atherosclerosis in mice. Arterioscler Thromb Vasc Biol, 2014,34(4):751–758
Machlus KR, Johnson KE, Kulenthirarajan R, et al. CCL5 derived from platelets increases megakaryocyte proplatelet formation. Blood, 2016,127(7):921–926
Zhou Y, Que KT, Zhang Z, et al. Iron overloaded polarizes macrophage to proinflammation phenotype through ROS/acetyl-p53 pathway. Cancer Med, 2018,7 (8):4012–4022
Handa P, Thomas S, Morgan-Stevenson V, et al. Iron alters macrophage polarization status and leads to steatohepatitis and fibrogenesis. J Leukoc Biol, 2019,105(5):1015–1026
Kapralov AA, Yang Q, Dar HH, et al. Redox lipid reprogramming commands susceptibility of macrophages and microglia to ferroptotic death. Nat Chem Biol, 2020,16(3):278–290
Sampilvanjil A, Karasawa T, Yamada N, et al. Cigarette smoke extract induces ferroptosis in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol, 2020,318(3):H508–H518
Jiang QW, Kaili D, Freeman J, et al. Diabetes inhibits corneal epithelial cell migration and tight junction formation in mice and human via increasing ROS and impairing Akt signaling. Acta Pharmacol Sin, 2019,40(9):1205–1211
Feng J, Wang J, Wang Y, et al. Oxidative Stress and Lipid Peroxidation: Prospective Associations Between Ferroptosis and Delayed Wound Healing in Diabetic Ulcers. Front Cell Dev Biol, 2022,10:898657
Cheng TL, Chen PK, Huang WK, et al. Plasminogen/thrombomodulin signaling enhances VEGF expression to promote cutaneous wound healing. J Mol Med (Berl), 2018,96(12):1333–1344
Icli B, Wu W, Ozdemir D, et al. MicroRNA-615-5p Regulates Angiogenesis and Tissue Repair by Targeting AKT/eNOS (Protein Kinase B/Endothelial Nitric Oxide Synthase) Signaling in Endothelial Cells. Arterioscler Thromb Vasc Biol, 2019,39(7):1458–1474
Bai T, Li M, Liu Y, et al. Inhibition of ferroptosis alleviates atherosclerosis through attenuating lipid peroxidation and endothelial dysfunction in mouse aortic endothelial cell. Free Radic Biol Med, 2020,160:92–102
Xiao FJ, Zhang D, Wu Y, et al. miRNA-17-92 protects endothelial cells from erastin-induced ferroptosis through targeting the A20–ACSL4 axis. Biochem Biophys Res Commun, 2019,515(3):448–454
You J, Ouyang S, Xie Z, et al. The suppression of hyperlipid diet-induced ferroptosis of vascular smooth muscle cells protests against atherosclerosis independent of p53/SCL7A11/GPX4 axis. J Cell Physiol, 2023,238(8):1891–1908
Liu W, Östberg N, Yalcinkaya M, et al. Erythroid lineage Jak2V617F expression promotes atherosclerosis through erythrophagocytosis and macrophage ferroptosis. J Clin Invest, 2022,132(13):e155724
Wang Y, Tang M. PM2.5 induces ferroptosis in human endothelial cells through iron overload and redox imbalance. Environ Pollut, 2019,254(Pt A):112937
Yao X, Xie R, Cao Y, et al. Simvastatin induced ferroptosis for triple-negative breast cancer therapy. J Nanobiotechnology, 2021,19(1):311
Zhang Q, Qu H, Chen Y, et al. Atorvastatin Induces Mitochondria-Dependent Ferroptosis via the Modulation of Nrf2-xCT/GPx4 Axis. Front Cell Dev Biol, 2022,10:806081
Jiao Y, Zhang T, Zhang C, et al. Exosomal miR-30d-5p of neutrophils induces M1 macrophage polarization and primes macrophage pyroptosis in sepsis-related acute lung injury. Crit Care, 2021,25(1):356
Robinson KS, Toh GA, Rozario P, et al. ZAKa-driven ribotoxic stress response activates the human NLRP1 inflammasome. Science, 2022,377(6603):328–335
Yu P, Zhang X, Liu N, et al. Pyroptosis: mechanisms and diseases. Signal Transduct Target Ther, 2021,6(1):128
He X, Fan X, Bai B, et al. Pyroptosis is a critical immune-inflammatory response involved in atherosclerosis. Pharmacol Res, 2021,165:105447
Zahid MDK, Rogowski M, Ponce C, et al. CCAAT/enhancer-binding protein beta (C/EBPβ) knockdown reduces inflammation, ER stress, and apoptosis, and promotes autophagy in oxLDL-treated RAW264.7 macrophage cells. Mol Cell Biochem, 2020,463(1–2):211–223
Chen S, Zuo Y, Huang L, et al. The MC(4) receptor agonist RO27-3225 inhibits NLRP1-dependent neuronal pyroptosis via the ASK1/JNK/p38 MAPK pathway in a mouse model of intracerebral haemorrhage. Br J Pharmacol, 2019,176(9):1341–1356
He Q, You H, Li XM, et al. HMGB1 promotes the synthesis of pro-IL-1β and pro-IL-18 by activation of p38 MAPK and NF-κB through receptors for advanced glycation end-products in macrophages. Asian Pac J Cancer Prev, 2012,13(4):1365–1370
Bai W, Huo T, Chen X, et al. Sacubitril/valsartan inhibits ox-LDL-induced MALAT1 expression, inflammation and apoptosis by suppressing the TLR4/NF-κB signaling pathway in HUVECs. Mol Med Rep, 2021,23(6):402
Zhang M, Xue Y, Chen H, et al. Resveratrol Inhibits MMP3 and MMP9 Expression and Secretion by Suppressing TLR4/NF-κB/STAT3 Activation in Ox-LDL-Treated HUVECs. Oxid Med Cell Longev, 2019,2019:9013169
Yang Y, Wang H, Kouadir M, et al. Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors. Cell Death Dis, 2019,10(2):128
Su J, Zhou H, Liu X, et al. oxLDL antibody inhibits MCP-1 release in monocytes/macrophages by regulating Ca(2+) /K(+) channel flow. J Cell Mol Med, 2017,21(5):929–940
Li HX, Kong FJ, Bai SZ, et al. Involvement of calcium-sensing receptor in oxLDL-induced MMP-2 production in vascular smooth muscle cells via PI3K/Akt pathway. Mol Cell Biochem, 2012,362(1–2):115–122
Zhan X, Li Q, Xu G, et al. The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors. Front Immunol, 2022,13:1109938
Zhaolin Z, Jiaojiao C, Peng W, et al. OxLDL induces vascular endothelial cell pyroptosis through miR-125a-5p/TET2 pathway. J Cell Physiol, 2019,234(5):7475–7491
Wang Y, Shi P, Chen Q, et al. Mitochondrial ROS promote macrophage pyroptosis by inducing GSDMD oxidation. J Mol Cell Biol, 2019,11(12):1069–1082
Zhang X, Zhang JH, Chen XY, et al. Reactive oxygen species-induced TXNIP drives fructose-mediated hepatic inflammation and lipid accumulation through NLRP3 inflammasome activation. Antioxid Redox Signal, 2015,22(10):848–870
Yang F, Qin Y, Wang Y, et al. Metformin Inhibits the NLRP3 Inflammasome via AMPK/mTOR-dependent Effects in Diabetic Cardiomyopathy. Int J Biol Sci, 2019,15(5):1010–1019
Lu Y, Lu Y, Meng J, et al. Pyroptosis and Its Regulation in Diabetic Cardiomyopathy. Front Physiol, 2021,12:791848
You L, Zheng Y, Yang J, et al. LncRNA MDRL Mitigates Atherosclerosis through miR-361/SQSTM1/NLRP3 Signaling. Mediators Inflamm, 2022,2022:5463505
Ahmadi A, Argulian E, Leipsic J, et al. From Subclinical Atherosclerosis to Plaque Progression and Acute Coronary Events: JACC State-of-the-Art Review. J Am Coll Cardiol, 2019,74(12):1608–1617
Khan R, Rheaume E, Tardif JC. Examining the Role of and Treatment Directed at IL-1β in Atherosclerosis. Curr Atheroscler Rep, 2018,20(11):53
Wu Q, He X, Wu LM, et al. MLKL Aggravates Ox-LDL-Induced Cell Pyroptosis via Activation of NLRP3 Inflammasome in Human Umbilical Vein Endothelial Cells. Inflammation, 2020,43(6):2222–2231
Huang P, Liu W, Chen J, et al. TRIM31 inhibits NLRP3 inflammasome and pyroptosis of retinal pigment epithelial cells through ubiquitination of NLRP3. Cell Biol Int, 2020,44(11):2213–2219
Chen J, Zhang C, Yan T, et al. Atorvastatin ameliorates early brain injury after subarachnoid hemorrhage via inhibition of pyroptosis and neuroinflammation. J Cell Physiol, 2021,236(10):6920–6931
Wu LM, Wu SG, Chen F, et al. Atorvastatin inhibits pyroptosis through the lncRNA NEXN-AS1/NEXN pathway in human vascular endothelial cells. Atherosclerosis, 2020,293:26–34
Ma S, Chen J, Feng J, et al. Melatonin Ameliorates the Progression of Atherosclerosis via Mitophagy Activation and NLRP3 Inflammasome Inhibition. Oxid Med Cell Longev, 2018,2018:9286458
Xing SS, Yang J, Li WJ, et al. Salidroside Decreases Atherosclerosis Plaque Formation via Inhibiting Endothelial Cell Pyroptosis. Inflammation, 2020,43(2): 433–440
Han Y, Qiu H, Pei X, et al. Low-dose Sinapic Acid Abates the Pyroptosis of Macrophages by Downregulation of lncRNA-MALAT1 in Rats With Diabetic Atherosclerosis. J Cardiovasc Pharmacol, 2018,71(2):104–112
Hu Q, Zhang T, Yi L, et al. Dihydromyricetin inhibits NLRP3 inflammasome-dependent pyroptosis by activating the Nrf2 signaling pathway in vascular endothelial cells. Biofactors, 2018,44(2):123–136
Martinet W, Schrijvers DM, Herman AG, et al. z-VAD-fmk-induced non-apoptotic cell death of macrophages: possibilities and limitations for atherosclerotic plaque stabilization. Autophagy, 2006,2(4):312–314
Chen J, Jiang Y, Shi H, et al. The molecular mechanisms of copper metabolism and its roles in human diseases. Pflugers Arch, 2020,472(10):1415–1429
Tsvetkov P, Coy S, Petrova B, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science, 2022,375(6586):1254–1261
Ruiz LM, Libedinsky A, Elorza AA. Role of Copper on Mitochondrial Function and Metabolism. Front Mol Biosci, 2021,8:711227
Zhang Z, Weichenthal S, Kwong JC, et al. A Population-Based Cohort Study of Respiratory Disease and LongTerm Exposure to Iron and Copper in Fine Particulate Air Pollution and Their Combined Impact on Reactive Oxygen Species Generation in Human Lungs. Environ Sci Technol, 2021,55(6):3807–3818
Koksal C, Ercan M, Bozkurt AK, et al. Abdominal aortic aneurysm or aortic occlusive disease: role of trace element imbalance. Angiology, 2007,58(2):191–195
Itoh S, Kim HW, Nakagawa O, et al. Novel role of antioxidant-1 (Atox1) as a copper-dependent transcription factor involved in cell proliferation. J Biol Chem, 2008,283(14):9157–9167
Das A, Sudhahar V, Ushio-Fukai M, et al. Novel interaction of antioxidant-1 with TRAF4: role in inflammatory responses in endothelial cells. Am J Physiol Cell Physiol, 2019,317(6):C1161–C1171
Wei H, Zhang WJ, McMillen TS, et al. Copper chelation by tetrathiomolybdate inhibits vascular inflammation and atherosclerotic lesion development in apolipoprotein E-deficient mice. Atherosclerosis, 2012,223(2):306–313
Alvarez HM, Xue Y, Robinson CD, et al. Tetrathiomolybdate inhibits copper trafficking proteins through metal cluster formation. Science, 2010,327 (5963):331–334
Vieceli Dalla Sega F, Fortini F, Aquila G, et al. Notch Signaling Regulates Immune Responses in Atherosclerosis. Front Immunol, 2019,10:1130
Bray SJ. Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol, 2006,7(9):678–689
Li H, Zhao L, Wang T, et al. Dietary Cholesterol Supplements Disturb Copper Homeostasis in Multiple Organs in Rabbits: Aorta Copper Concentrations Negatively Correlate with the Severity of Atherosclerotic Lesions. Biol Trace Elem Res, 2022,200(1):164–171
Bügel S, Harper A, Rock E, et al. Effect of copper supplementation on indices of copper status and certain CVD risk markers in young healthy women. Br J Nutr, 2005,94(2):231–236
Fortini F, Vieceli Dalla Sega F, Caliceti C, et al. Estrogen receptor β-dependent Notchl activation protects vascular endothelium against tumor necrosis factor a (TNFa)-induced apoptosis. J Biol Chem, 2017,292(44):18178–18191
Fortini F, Vieceli Dalla Sega F, Caliceti C, et al. Estrogen-mediated protection against coronary heart disease: The role of the Notch pathway. J Steroid Biochem Mol Biol, 2019,189:87–100
Martos-Rodríguez CJ, Albarrán-Juárez J, Morales-Cano D, et al. Fibrous Caps in Atherosclerosis Form by Notch-Dependent Mechanisms Common to Arterial Media Development. Arterioscler Thromb Vasc Biol, 2021,41(9):e427–e439
Green DR. The Coming Decade of Cell Death Research: Five Riddles. Cell, 2019,177(5):1094–1107
Tao X, Wan X, Wu D, et al. A tandem activation of NLRP3 inflammasome induced by copper oxide nanoparticles and dissolved copper ion in J774A.1 macrophage. J Hazard Mater, 2021,411:125134
Mehrotra P, Ravichandran KS. Drugging the efferocytosis process: concepts and opportunities. Nat Rev Drug Discov, 2022,21(8):601–620
Pertiwi KR, de Boer OJ, Mackaaij C, et al. Extracellular traps derived from macrophages, mast cells, eosinophils and neutrophils are generated in a time-dependent manner during atherothrombosis. J Pathol, 2019,247(4):505–512
Mitra S, Deshmukh A, Sachdeva R, et al. Oxidized low-density lipoprotein and atherosclerosis implications in antioxidant therapy. Am J Med Sci, 2011,342(2):135–142
Lee C, Cheng W, Chang M, et al. Hypoxia-induced apoptosis in endothelial cells and embryonic stem cells. Apoptosis, 2005,10(4):887–894
Zhang Y, Xie Y, You S, et al. Autophagy and Apoptosis in the Response of Human Vascular Endothelial Cells to Oxidized Low-Density Lipoprotein. Cardiology, 2015,132(1):27–33
Henson PM. Cell Removal: Efferocytosis. Annu Rev Cell Dev Biol, 2017,33:127–144
Morioka S, Maueröder C, Ravichandran KS. Living on the Edge: Efferocytosis at the Interface of Homeostasis and Pathology. Immunity, 2019,50(5):1149–1162
Lauber K, Bohn E, Kröber SM, et al. Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell, 2003,113(6):717–730
Elliott MR, Chekeni FB, Trampont PC, et al. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature, 2009,461(7261):282–286
Segawa K, Kurata S, Yanagihashi Y, et al. Caspase-mediated cleavage of phospholipid flippase for apoptotic phosphatidylserine exposure. Science, 2014,344(6188): 1164–1168
Suzuki J, Denning DP, Imanishi E, et al. Xk-related - protein 8 and CED-8 promote phosphatidylserine exposure in apoptotic cells. Science, 2013,341(6144): 403–406
Oka K, Sawamura T, Kikuta K, et al. Lectin-like oxidized low-density lipoprotein receptor 1 mediates phagocytosis of aged/apoptotic cells in endothelial cells. Proc Natl Acad Sci USA, 1998,95(16):9535–9540
Chang MK, Bergmark C, Laurila A, et al. Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition. Proc Natl Acad Sci USA, 1999,96(11):6353–6358
Barclay AN, Van den Berg TK. The interaction between signal regulatory protein alpha (SIRPa) and CD47: structure, function, and therapeutic target. Annu Rev Immunol, 2014,32:25–50
Nakahashi-Oda C, Fujiyama S, Nakazawa Y, et al. CD300a blockade enhances efferocytosis by infiltrating myeloid cells and ameliorates neuronal deficit after ischemic stroke. Sci Immunol, 2021,6(64):eabe7915
Green DR, Oguin TH, Martinez J. The clearance of dying cells: table for two. Cell Death Differ, 2016,23(6):915–926
Heckmann BL, Green DR. LC3-associated phagocytosis at a glance. J Cell Sci, 2019,132(5):jcs222984
Thorp E, Vaisar T, Subramanian M, et al. Shedding of the Mer tyrosine kinase receptor is mediated by ADAM17 protein through a pathway involving reactive oxygen species, protein kinase CS, and p38 mitogen-activated protein kinase (MAPK). J Biol Chem, 2011,286(38):33335–33344
Komura H, Miksa M, Wu R, et al. Milk fat globule epidermal growth factor-factor VIII is down-regulated in sepsis via the lipopolysaccharide-CD14 pathway. J Immunol, 2009,182(1):581–587
Kawai T, Elliott KJ, Scalia R, et al. Contribution of ADAM17 and related ADAMs in cardiovascular diseases. Cell Mol Life Sci, 2021,78(9):4161–4187
Zhang Y, Wang Y, Zhou D, et al. Angiotensin II deteriorates advanced atherosclerosis by promoting MerTK cleavage and impairing efferocytosis through the AT(1)R/ROS/p38 MAPK/ADAM17 pathway. Am J Physiol Cell Physiol, 2019,317(4):C776–C787
Nanda V, Downing KP, Ye J, et al. CDKN2B Regulates TGFβ Signaling and Smooth Muscle Cell Investment of Hypoxic Neovessels. Circ Res, 2016,118(2):230–240
Leeper NJ, Raiesdana A, Kojima Y, et al. Loss of CDKN2B promotes p53-dependent smooth muscle cell apoptosis and aneurysm formation. Arterioscler Thromb Vasc Biol, 2013,33(1):e1–e10
Singla B, Lin HP, Ahn W, et al. Loss of myeloid cell-specific SIRPa, but not CD47, attenuates inflammation and suppresses atherosclerosis. Cardiovasc Res, 2022,118(15):3097–3111
Schrijvers DM, De Meyer GR, Herman AG, et al. Phagocytosis in atherosclerosis: Molecular mechanisms and implications for plaque progression and stability. Cardiovasc Res, 2007,73(3):470–480
Shaw PX, Hörkkö S, Tsimikas S, et al. Human-derived anti-oxidized LDL autoantibody blocks uptake of oxidized LDL by macrophages and localizes to atherosclerotic lesions in vivo. Arterioscler Thromb Vasc Biol, 2001,21(8):1333–1339
Martinet W, Schrijvers DM, De Meyer GR. Necrotic cell death in atherosclerosis. Basic Res Cardiol, 2011,106(5):749–760
Schrijvers DM, De Meyer GR, Kockx MM, et al. Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis. Arterioscler Thromb Vasc Biol, 2005,25(6):1256–1261
Kojima Y, Downing K, Kundu R, et al. Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis. J Clin Invest, 2014,124(3):1083–1097
Proto JD, Doran AC, Gusarova G, et al. Regulatory T Cells Promote Macrophage Efferocytosis during Inflammation Resolution. Immunity, 2018,49(4):666–677.e6
Wei YT, Wang XR, Yan C, et al. Thymosin a-l Reverses M2 Polarization of Tumor-Associated Macrophages during Efferocytosis. Cancer Res, 2022,82(10):1991–2002
Chen W, Li L, Wang J, et al. The ABCA1-efferocytosis axis: A new strategy to protect against atherosclerosis. Clin Chim Acta, 2021,518:1–8
Yurdagul A, Jr. Crosstalk Between Macrophages and Vascular Smooth Muscle Cells in Atherosclerotic Plaque Stability. Arterioscler Thromb Vasc Biol, 2022,42 (4):372–380
Cai B, Thorp EB, Doran AC, et al. MerTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis. J Clin Invest, 2017,127 (2):564–568
Ait-Oufella H, Kinugawa K, Zoll J, et al. Lactadherin deficiency leads to apoptotic cell accumulation and accelerated atherosclerosis in mice. Circulation, 2007, 115(16):2168–2177
Wei Y, Zhu M, Corbalán-Campos J, et al. Regulation of Csf1r and Bcl6 in macrophages mediates the stage-specific effects of microRNA-155 on atherosclerosis. Arterioscler Thromb Vasc Biol, 2015,35(4):796–803
Khanna S, Biswas S, Shang Y, et al. Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice. PLoS One, 2010,5(3):e9539
Mahmoudi A, Firouzjaei AA, Darijani F, et al. Effect of diabetes on efferocytosis process. Mol Biol Rep, 2022,49(11):10849–10863
Petkovic A, Erceg S, Munjas J, et al. LncRNAs as Regulators of Atherosclerotic Plaque Stability. Cells, 2023,12(14):1832
Ye ZM, Yang S, Xia YP, et al. LncRNA MIAT sponges miR-149-5p to inhibit efferocytosis in advanced atherosclerosis through CD47 upregulation. Cell Death Dis, 2019,10(2):138
Kojima Y, Volkmer JP, McKenna K, et al. CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis. Nature, 2016,536(7614):86–90
Gerlach BD, Marinello M, Heinz J, et al. Resolvin D1 promotes the targeting and clearance of necroptotic cells. Cell Death Differ, 2020,27(2):525–539
Azcutia V, Routledge M, Williams MR, et al. CD47 plays a critical role in T-cell recruitment by regulation of LFA-1 and VLA-4 integrin adhesive functions. Mol Biol Cell, 2013,24(21):3358–3368
Tosello-Trampont AC, Nakada-Tsukui K, Ravichandran KS. Engulfment of apoptotic cells is negatively regulated by Rho-mediated signaling. J Biol Chem, 2003,278(50):49911–49919
Wu DJ, Xu JZ, Wu YJ, et al. Effects of fasudil on early atherosclerotic plaque formation and established lesion progression in apolipoprotein E-knockout mice. Atherosclerosis, 2009,207(1):68–73
Flores AM, Hosseini-Nassab N, Jarr KU, et al. Proefferocytic nanoparticles are specifically taken up by lesional macrophages and prevent atherosclerosis. Nat Nanotechnol, 2020,15(2):154–161
Döring Y, Soehnlein O, Weber C. Neutrophil Extracellular Traps in Atherosclerosis and Atherothrombosis. Circ Res, 2017,120(4):736–743
Yipp BG, Petri B, Salina D, et al. Infection-induced NETosis is a dynamic process involving neutrophil multitasking in vivo. Nat Med, 2012,18(9):1386–1393
Pilsczek FH, Salina D, Poon KK, et al. A novel mechanism of rapid nuclear neutrophil extracellular trap formation in response to Staphylococcus aureus. J Immunol, 2010,185(12):7413–7425
Brinkmann V, Reichard U, Goosmann C, et al. Neutrophil extracellular traps kill bacteria. Science, 2004,303(5663):1532–1535
Nakazawa D, Desai J, Steiger S, et al. Activated platelets induce MLKL-driven neutrophil necroptosis and release of neutrophil extracellular traps in venous thrombosis. Cell Death Discov, 2018,4:6
Schreiber A, Rousselle A, Becker JU, et al. Necroptosis controls NET generation and mediates complement activation, endothelial damage, and autoimmune vasculitis. Proc Natl Acad Sci USA, 2017,114(45):E9618–E9625
Chen KW, Monteleone M, Boucher D, et al. Noncanonical inflammasome signaling elicits gasdermin D-dependent neutrophil extracellular traps. Sci Immunol, 2018,3(26):eaar6676
Quillard T, Araújo HA, Franck G, et al. TLR2 and neutrophils potentiate endothelial stress, apoptosis and detachment: implications for superficial erosion. Eur Heart J, 2015,36(22):1394–1404
Pertiwi KR, van der Wal AC, Pabittei DR, et al. Neutrophil Extracellular Traps Participate in All Different Types of Thrombotic and Haemorrhagic Complications of Coronary Atherosclerosis. Thromb Haemost, 2018,118(6):1078–1087
Carmona-Rivera C, Zhao W, Yalavarthi S, et al. Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase-2. Ann Rheum Dis, 2015,74(7):1417–1424
Döring Y, Manthey HD, Drechsler M, et al. Auto-antigenic protein-DNA complexes stimulate plasmacytoid dendritic cells to promote atherosclerosis. Circulation, 2012,125(13):1673–1683
Chen HJ, Tas SW, de Winther MPJ. Type-I interferons in atherosclerosis. J Exp Med, 2020,217(1):e20190459
Ding X, Xiang W, He X. IFN-I Mediates Dysfunction of Endothelial Progenitor Cells in Atherosclerosis of Systemic Lupus Erythematosus. Front Immunol, 2020,11:581385
Borissoff JI, Joosen IA, Versteylen MO, et al. Elevated levels of circulating DNA and chromatin are independently associated with severe coronary atherosclerosis and a prothrombotic state. Arterioscler Thromb Vasc Biol, 2013,33(8):2032–2040
Zhai M, Gong S, Luan P, et al. Extracellular traps from activated vascular smooth muscle cells drive the progression of atherosclerosis. Nat Commun, 2022,13(1):7500
Zhang YG, Song Y, Guo XL, et al. Exosomes derived from oxLDL-stimulated macrophages induce neutrophil extracellular traps to drive atherosclerosis. Cell Cycle, 2019,18(20):2674–2684
Wang W, Jin Y, Zeng N, et al. SOD2 Facilitates the Antiviral Innate Immune Response by Scavenging Reactive Oxygen Species. Viral Immunol, 2017,30(8): 582–589
Chen L, Hu L, Li Q, et al. Exosome-encapsulated miR-505 from ox-LDL-treated vascular endothelial cells aggravates atherosclerosis by inducing NET formation. Acta Biochim Biophys Sin (Shanghai), 2019,51(12):1233–1241
Warnatsch A, Ioannou M, Wang Q, et al. Inflammation. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis. Science, 2015,349(6245):316–320
Davis JC, Jr., Manzi S, Yarboro C, et al. Recombinant human Dnase I (rhDNase) in patients with lupus nephritis. Lupus, 1999,8(1):68–76
Li N, Zheng X, Chen M, et al. Deficient DNASE1L3 facilitates neutrophil extracellular traps-induced invasion via cyclic GMP-AMP synthase and the non-canonical NF-κB pathway in diabetic hepatocellular carcinoma. Clin Transl Immunology, 2022,11(4):e1386
Rohrbach AS, Slade DJ, Thompson PR, et al. Activation of PAD4 in NET formation. Front Immunol, 2012,3:360
Knight JS, Luo W, O’Dell AA, et al. Peptidylargmme deiminase inhibition reduces vascular damage and modulates innate immune responses in murine models of atherosclerosis. Circ Res, 2014,114(6):947–956
Chen YR, Xiang XD, Sun F, et al. Simvastatin Reduces NETosis to Attenuate Severe Asthma by Inhibiting PAD4 Expression. Oxid Med Cell Longev, 2023,2023:1493684
Al-Ghoul WM, Kim MS, Fazal N, et al. Evidence for simvastatin anti-inflammatory actions based on quantitative analyses of NETosis and other inflam-mation/oxidation markers. Results Immunol, 2014,4:14–22
Huang SU, O’Sullivan KM. The Expanding Role of Extracellular Traps in Inflammation and Autoimmunity: The New Players in Casting Dark Webs. Int J Mol Sci, 2022,23(7):3793
Yousefi S, Mihalache C, Kozlowski E, et al. Viable neutrophils release mitochondrial DNA to form neutrophil extracellular traps. Cell Death Differ, 2009,16(11):1438–1444
Keshari RS, Jyoti A, Dubey M, et al. Cytokines induced neutrophil extracellular traps formation: implication for the inflammatory disease condition. PLoS One, 2012,7(10):e48111
Knight JS, Carmona-Rivera C, Kaplan MJ. Proteins derived from neutrophil extracellular traps may serve as self-antigens and mediate organ damage in autoimmune diseases. Front Immunol, 2012,3:380
Csomós K, Kristóf E, Jakob B, et al. Protein cross-linking by chlorinated polyamines and transglutamylation stabilizes neutrophil extracellular traps. Cell Death Dis, 2016,7(8):e2332
King PT, Sharma R, O’Sullivan K, et al. Nontypeable Haemophilus influenzae induces sustained lung oxidative stress and protease expression. PLoS One, 2015,10(3):e0120371
Liu P, Wu X, Liao C, et al. Escherichia coli and Candida albicans induced macrophage extracellular trap-like structures with limited microbicidal activity. PLoS One, 2014,9(2):e90042
King PT, Sharma R, O’Sullivan KM, et al. Deoxyribonuclease 1 reduces pathogenic effects of cigarette smoke exposure in the lung. Sci Rep, 2017,7(1):12128
O’Sullivan KM, Lo CY, Summers SA, et al. Renal participation of myeloperoxidase in antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis. Kidney Int, 2015,88(5):1030–1046
Lauth X, von Köckritz-Blickwede M, McNamara CW, et al. M1 protein allows Group A streptococcal survival in phagocyte extracellular traps through cathelicidin inhibition. J Innate Immun, 2009,1(3):202–214
Garcia-Rodríguez KM, Bahri R, Sattentau C, et al. Human mast cells exhibit an individualized pattern of antimicrobial responses. Immun Inflamm Dis, 2020,8(2):198–210
von Köckritz-Blickwede M, Goldmann O, Thulin P, et al. Phagocytosis-independent antimicrobial activity of mast cells by means of extracellular trap formation. Blood, 2008,111(6):3070–3080
Nija RJ, Sanju S, Sidharthan N, et al. Extracellular Trap by Blood Cells: Clinical Implications. Tissue Eng Regen Med, 2020,17(2):141–153
Lin AM, Rubin CJ, Khandpur R, et al. Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. J Immunol, 2011,187(1):490–500
Yousefi S, Gold JA, Andina N, et al. Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense. Nat Med, 2008,14(9):949–953
Ueki S, Melo RC, Ghiran I, et al. Eosinophil extracellular DNA trap cell death mediates lytic release of free secretion-competent eosinophil granules in humans. Blood, 2013,121(11):2074–2083
Yousefi S, Morshed M, Amini P, et al. Basophils exhibit antibacterial activity through extracellular trap formation. Allergy, 2015,70(9):1184–1188
Loures FV, Röhm M, Lee CK, et al. Recognition of Aspergillus fumigatus hyphae by human plasmacytoid dendritic cells is mediated by dectin-2 and results in formation of extracellular traps. PLoS Pathog, 2015,11(2):e1004643
Gimbrone MA, Jr., García-Cardeña G. Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis. Circ Res, 2016,118(4):620–636
Sawma T, Shaito A, Najm N, et al. Role of RhoA and Rho-associated kinase in phenotypic switching of vascular smooth muscle cells: Implications for vascular function. Atherosclerosis, 2022,358:12–28
Miralles F, Posern G, Zaromytidou AI, et al. Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell, 2003,113(3):329–342
Qi Y, Liang X, Dai F, et al. RhoA/ROCK Pathway Activation is Regulated by AT1 Receptor and Participates in Smooth Muscle Migration and Dedifferentiation via Promoting Actin Cytoskeleton Polymerization. Int J Mol Sci, 2020,21(15):5398
Kloc M, Kubiak JZ, Ghobrial RM. Macrophage-, Dendritic-, Smooth Muscle-, Endothelium-, and Stem Cells-Derived Foam Cells in Atherosclerosis. Int J Mol Sci, 2022,23(22):14154
Allahverdian S, Chehroudi AC, McManus BM, et al. Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis. Circulation, 2014,129(15):1551–1559
Wang Y, Dubland JA, Allahverdian S, et al. Smooth Muscle Cells Contribute the Majority of Foam Cells in ApoE (Apolipoprotein E)-Deficient Mouse Atherosclerosis. Arterioscler Thromb Vasc Biol, 2019, 39(5):876–887
Dubland JA, Francis GA. So Much Cholesterol: the unrecognized importance of smooth muscle cells in atherosclerotic foam cell formation. Curr Opin Lipidol, 2016,27(2):155–161
Costales P, Fuentes-Prior P, Castellano J, et al. K Domain CR9 of Low Density Lipoprotein (LDL) Receptor-related Protein 1 (LRP1) Is Critical for Aggregated LDL-induced Foam Cell Formation from Human Vascular Smooth Muscle Cells. J Biol Chem, 2015,290(24):14852–14865
Yin YW, Liao SQ, Zhang MJ, et al. TLR4-mediated inflammation promotes foam cell formation of vascular smooth muscle cell by upregulating ACAT1 expression. Cell Death Dis, 2014,5(12):e1574
Chen Z, Xue Q, Cao L, et al. Toll-Like Receptor 4 Mediated Oxidized Low-Density Lipoprotein-Induced Foam Cell Formation in Vascular Smooth Muscle Cells via Src and Sirt1/3 Pathway. Mediators Inflamm, 2021,2021:6639252
Gabunia K, Herman AB, Ray M, et al. Induction of MiR133a expression by IL-19 targets LDLRAP1 and reduces oxLDL uptake in VSMC. J Mol Cell Cardiol, 2017,105:38–48
Fan Y, Zhang J, Chen CY, et al. Macrophage migration inhibitory factor triggers vascular smooth muscle cell dedifferentiation by a p68-serum response factor axis. Cardiovasc Res, 2017,113(5):519–530
Shankman LS, Gomez D, Cherepanova OA, et al. KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis. Nat Med, 2015,21(6):628–637
Vendrov AE, Sumida A, Canugovi C, et al. NOXA1-dependent NADPH oxidase regulates redox signaling and phenotype of vascular smooth muscle cell during atherogenesis. Redox Biol, 2019,21:101063
Wu JH, Zhang L, Nepliouev I, et al. Drebrin attenuates atherosclerosis by limiting smooth muscle cell transdifferentiation. Cardiovasc Res, 2022,118(3):772–784
Chen C, Wang Y, Yang S, et al. MiR-320a contributes to atherogenesis by augmenting multiple risk factors and down-regulating SRF. J Cell Mol Med, 2015,19(5):970–985
Karolina DS, Tavintharan S, Armugam A, et al. Circulating miRNA profiles in patients with metabolic syndrome. J Clin Endocrinol Metab, 2012,97(12): E2271–E2276
Zhang C, Wang X. miR-320a Targeting RGS5 Aggravates Atherosclerosis by Promoting Migration and Proliferation of ox-LDL-Stimulated Vascular Smooth Muscle Cells. J Cardiovasc Pharmacol, 2022,80(1):110–117
Haka AS, Singh RK, Grosheva I, et al. Monocyte-Derived Dendritic Cells Upregulate Extracellular Catabolism of Aggregated Low-Density Lipoprotein on Maturation, Leading to Foam Cell Formation. Arterioscler Thromb Vasc Biol, 2015,35(10):2092–2103
Stellos K, Seizer P, Bigalke B, et al. Platelet aggregates-induced human CD34+ progenitor cell proliferation and differentiation to macrophages and foam cells is mediated by stromal cell derived factor 1 in vitro. Semin Thromb Hemost, 2010,36(2):139–145
Corrêa R, Silva LFF, Ribeiro DJS, et al. Lysophosphatidylcholine Induces NLRP3 Inflammasome-Mediated Foam Cell Formation and Pyroptosis in Human Monocytes and Endothelial Cells. Front Immunol, 2019,10:2927
Tada Y, Yano S, Yamaguchi T, et al. Advanced glycation end products-induced vascular calcification is mediated by oxidative stress: functional roles of NAD(P) H-oxidase. Horm Metab Res, 2013,45(4):267–272
Goettsch C, Rauner M, Hamann C, et al. Nuclear factor of activated T cells mediates oxidised LDL-induced calcification of vascular smooth muscle cells. Diabetologia, 2011,54(10):2690–2701
Alencar GF, Owsiany KM, Karnewar S, et al. Stem Cell Pluripotency Genes Klf4 and Oct4 Regulate Complex SMC Phenotypic Changes Critical in Late-Stage Atherosclerotic Lesion Pathogenesis. Circulation, 2020,142(21):2045–2059
Parhami F, Basseri B, Hwang J, et al. High-density lipoprotein regulates calcification of vascular cells. Circ Res, 2002,91(7):570–576
Fochi S, Giuriato G, De Simone T, et al. Regulation of microRNAs in Satellite Cell Renewal, Muscle Function, Sarcopenia and the Role of Exercise. Int J Mol Sci, 2020,21(18):6732
Shanahan CM, Crouthamel MH, Kapustin A, et al. Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ Res, 2011,109(6):697–711
Zhang F, Guo X, Xia Y, et al. An update on the phenotypic switching of vascular smooth muscle cells in the pathogenesis of atherosclerosis. Cell Mol Life Sci, 2021,79(1):6
Shroff RC, Shanahan CM. The vascular biology of calcification. Semin Dial, 2007,20(2):103–109
Badi I, Mancinelli L, Polizzotto A, et al. miR-34a Promotes Vascular Smooth Muscle Cell Calcification by Downregulating SIRT1 (Sirturn 1) and Axl (AXL Receptor Tyrosine Kinase). Arterioscler Thromb Vasc Biol, 2018,38(9):2079–2090
Di Bartolo BA, Schoppet M, Mattar MZ, et al. Calcium and osteoprotegerin regulate IGF1R expression to inhibit vascular calcification. Cardiovasc Res, 2011,91(3):537–545
Kanno Y, Into T, Lowenstein CJ, et al. Nitric oxide regulates vascular calcification by interfering with TGF- signalling. Cardiovasc Res, 2008,77(1):221–230
Oh YJ, Kim H, Kim AJ, et al. Reduction of Secreted Frizzled-Related Protein 5 Drives Vascular Calcification through Wnt3a-Mediated Rho/ROCK/JNK Signaling in Chronic Kidney Disease. Int J Mol Sci, 2020,21(10):3539
Naik V, Leaf EM, Hu JH, et al. Sources of cells that contribute to atherosclerotic intimal calcification: an in vivo genetic fate mapping study. Cardiovasc Res, 2012,94(3):545–554
Alexopoulos N, Raggi P. Calcification in atherosclerosis. Nat Rev Cardiol, 2009,6(11):681–688
Huang H, Virmani R, Younis H, et al. The impact of calcification on the biomechanical stability of atherosclerotic plaques. Circulation, 2001,103(8):1051–1056
Beckman JA, Ganz J, Creager MA, et al. Relationship of clinical presentation and calcification of culprit coronary artery stenoses. Arterioscler Thromb Vasc Biol, 2001,21(10):1618–1622
Mosseri M, Satler LF, Pichard AD, et al. Impact of vessel calcification on outcomes after coronary stenting. Cardiovasc Revasc Med, 2005,6(4):147–153
Venkitachalam L, Mackey RH, Sutton-Tyrrell K, et al. Elevated pulse wave velocity increases the odds of coronary calcification in overweight postmenopausal women. Am J Hypertens, 2007,20(5):469–475
Ramadan MM, Mahfouz EM, Gomaa GF, et al. Evaluation of coronary calcium score by multidetector computed tomography in relation to endothelial function and inflammatory markers in asymptomatic individuals. Circ J, 2008,72(5):778–785
Ehara S, Kobayashi Y, Yoshiyama M, et al. Spotty calcification typifies the culprit plaque in patients with acute myocardial infarction: an intravascular ultrasound study. Circulation, 2004,110(22):3424–3429
Motoyama S, Kondo T, Sarai M, et al. Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes. J Am Coll Cardiol, 2007,50(4):319–326
Wirka RC, Wagh D, Paik DT, et al. Atheroprotective roles of smooth muscle cell phenotypic modulation and the TCF21 disease gene as revealed by single-cell analysis. Nat Med, 2019,25(8):1280–1289
Miller CL, Haas U, Diaz R, et al. Coronary heart disease-associated variation in TCF21 disrupts a miR-224 binding site and miRNA-mediated regulation. PLoS Genet, 2014,10(3):e1004263
Lee HN, Choi YY, Kim JW, et al. Effect of biochemical and biomechanical factors on vascularization of kidney organoid-on-a-chip. Nano Converg, 2021,8(1):35
Chanda PK, Meng S, Lee J, et al. Nuclear S-Nitrosylation Defines an Optimal Zone for Inducing Pluripotency. Circulation, 2019,140(13):1081–1099
Hong X, Margariti A, Le Bras A, et al. Transdifferentiated Human Vascular Smooth Muscle Cells are a New Potential Cell Source for Endothelial Regeneration. Sci Rep, 2017,7(1):5590
Grootaert MOJ, Bennett MR. Vascular smooth muscle cells in atherosclerosis: time for a re-assessment. Cardiovasc Res, 2021,117(11):2326–2339
Nguyen Dinh Cat A, Briones AM, Callera GE, et al. Adipocyte-derived factors regulate vascular smooth muscle cells through mineralocorticoid and glucocorticoid receptors. Hypertension, 2011,58(3):479–488
Chen PY, Qin L, Li G, et al. Smooth Muscle Cell Reprogramming in Aortic Aneurysms. Cell Stem Cell, 2020,26(4):542–557
Hergenreider E, Heydt S, Tréguer K, et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol, 2012,14(3):249–356
Dong K, Shen J, He X, et al. CARMN Is an Evolutionarily Conserved Smooth Muscle Cell-Specific LncRNA That Maintains Contractile Phenotype by Binding Myocardin. Circulation, 2021,144(23):1856–1875
Hicks CW, Daya NR, Black JH,3rd, et al. Race and sex-based disparities associated with carotid endarterectomy in the Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis, 2020,292:10–16
Salemi S, Prange JA, Baumgartner V, et al. Adult stem cell sources for skeletal and smooth muscle tissue engineering. Stem Cell Res Ther, 2022,13(1):156
Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science, 1999,284(5411):143–147
Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature, 2002,418(6893):41–49
Huang P, Wang L, Li Q, et al. Atorvastatin enhances the therapeutic efficacy of mesenchymal stem cells-derived exosomes in acute myocardial infarction via up-regulating long non-coding RNA H19. Cardiovasc Res, 2020,116(2):353–367
Xiong Y, Tang R, Xu J, et al. Sequential transplantation of exosomes and mesenchymal stem cells pretreated with a combination of hypoxia and Tongxinluo efficiently facilitates cardiac repair. Stem Cell Res Ther, 2022,13(1):63
Ning Y, Huang P, Chen G, et al. Atorvastatin-pretreated mesenchymal stem cell-derived extracellular vesicles promote cardiac repair after myocardial infarction via shifting macrophage polarization by targeting microRNA-139-3p/Stat1 pathway. BMC Med, 2023,21 (1):96
George J, Afek A, Abashidze A, et al. Transfer of endothelial progenitor and bone marrow cells influences atherosclerotic plaque size and composition in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol, 2005,25(12):2636–2641
Tousoulis D, Briasoulis A, Vogiatzi G, et al. Infusion of lin-/sca-1+ and endothelial progenitor cells improves proinflammatory and oxidative stress markers in atherosclerotic mice. Int J Cardiol, 2013,167(5):1900–1905
Wei X, Sun G, Zhao X, et al. Human amnion mesenchymal stem cells attenuate atherosclerosis by modulating macrophage function to reduce immune response. Int J Mol Med, 2019,44(4):1425–1435
Li Q, Sun W, Wang X, et al. Skin-Derived Mesenchymal Stem Cells Alleviate Atherosclerosis via Modulating Macrophage Function. Stem Cells Transl Med, 2015,4(11):1294–1301
Wang SS, Hu SW, Zhang QH, et al. Mesenchymal Stem Cells Stabilize Atherosclerotic Vulnerable Plaque by Anti-Inflammatory Properties. PLoS One, 2015,10(8):e0136026
Frodermann V, van Duijn J, van Pel M, et al. Mesenchymal Stem Cells Reduce Murine Atherosclerosis Development. Sci Rep, 2015,5:15559
Mu Y, Xu W, Liu J, et al. Mesenchymal stem cells moderate experimental autoimmune uveitis by dynamic regulating Th17 and Breg cells response. J Tissue Eng Regen Med, 2022,16(1):26–35
Zhang X, Huang F, Li W, et al. Human Gingiva-Derived Mesenchymal Stem Cells Modulate Monocytes/Macrophages and Alleviate Atherosclerosis. Front Immunol, 2018,9:878
Li JZ, Cao TH, Han JC, et al. Comparison of adipose- and bone marrow-derived stem cells in protecting against ox-LDL-induced inflammation in M1-macrophage-derived foam cells. Mol Med Rep, 2019,19(4):2660–2670
Hong R, Wang Z, Sui A, et al. Gingival mesenchymal stem cells attenuate pro-inflammatory macrophages stimulated with oxidized low-density lipoprotein and modulate lipid metabolism. Arch Oral Biol, 2019,98:92–98
Sharma M, Schlegel MP, Afonso MS, et al. Regulatory T Cells License Macrophage Pro-Resolving Functions During Atherosclerosis Regression. Circ Res, 2020,127 (3):335–353
Fazio S, Babaev VR, Murray AB, et al. Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages. Proc Natl Acad Sci USA, 1997,94(9):4647–4652
Van Eck M, Herijgers N, Vidgeon-Hart M, et al. Accelerated atherosclerosis in C57Bl/6 mice transplanted with ApoE-deficient bone marrow. Atherosclerosis, 2000,150(1):71–80
Yu B, Chen Q, Le Bras A, et al. Vascular Stem/Progenitor Cell Migration and Differentiation in Atherosclerosis. Antioxid Redox Signal, 2018,29(2):219–235
Rauscher FM, Goldschmidt-Clermont PJ, Davis BH, et al. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation, 2003,108(4):457–463
Zhang Z, Li Z, Wang Y, et al. PDGF-BB/SA/Dex injectable hydrogels accelerate BMSC-mediated functional full thickness skin wound repair by promoting angiogenesis. J Mater Chem B, 2021,9(31):6176–6189
Linton MF, Atkinson JB, Fazio S. Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation. Science, 1995,267 (5200):1034–1037
Herijgers N, Van Eck M, Groot PH, et al. Effect of bone marrow transplantation on lipoprotein metabolism and atherosclerosis in LDL receptor-knockout mice. Arterioscler Thromb Vasc Biol, 1997,17(10):1995–2003
Nelson WD, Zenovich AG, Ott HC, et al. Sex-dependent attenuation of plaque growth after treatment with bone marrow mononuclear cells. Circ Res, 2007,101(12):1319–1327
Li Y, Shi G, Han Y, et al. Therapeutic potential of human umbilical cord mesenchymal stem cells on aortic atherosclerotic plaque in a high-fat diet rabbit model. Stem Cell Res Ther, 2021,12(1):407
Bromage DI, Davidson SM, Yellon DM. Stromal derived factor la: a chemokine that delivers a two-pronged defence of the myocardium. Pharmacol Ther, 2014,143(3):305–315
Lawson C, Wolf S. ICAM-1 signaling in endothelial cells. Pharmacol Rep, 2009,61(1):22–32
Merckelbach S, van der Vorst EPC, Kallmayer M, et al. Expression and Cellular Localization of CXCR4 and CXCL12 in Human Carotid Atherosclerotic Plaques. Thromb Haemost, 2018,118(1):195–206
Chatterjee M, von Ungern-Sternberg SN, Seizer P, et al. Platelet-derived CXCL12 regulates monocyte function, survival, differentiation into macrophages and foam cells through differential involvement of CXCR4-CXCR7. Cell Death Dis, 2015,6(11):e1989
Nahrendorf M, Jaffer FA, Kelly KA, et al. Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation, 2006,114(14):1504–1511
Hassanzadeh A, Shamlou S, Yousefi N, et al. Genetically-modified Stem Cell in Regenerative Medicine and Cancer Therapy; A New Era. Curr Gene Ther, 2022,22(1):23–39
Cheng G, Wang X, Li Y, et al. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling. Stem Cell Res Ther, 2017,8(1):34
Tao X, Sun M, Chen M, et al. HMGB1-modified mesenchymal stem cells attenuate radiation-induced vascular injury possibly via their high motility and facilitation of endothelial differentiation. Stem Cell Res Ther, 2019,10(1):92
Tian XQ, Yang YJ, Li Q, et al. Combined therapy with atorvastatin and atorvastatin-pretreated mesenchymal stem cells enhances cardiac performance after acute myocardial infarction by activating SDF-1/CXCR4 axis. Am J Transl Res, 2019,11(7):4214–4231
Shafei AE, Ali MA, Ghanem HG, et al. Mesenchymal stem cell therapy: A promising cell-based therapy for treatment of myocardial infarction. J Gene Med, 2017,19(12). doi: https://doi.org/10.1002/jgm.2995
Maeda T, Mandai M, Sugita S, et al. Strategies of pluripotent stem cell-based therapy for retinal degeneration: update and challenges. Trends Mol Med, 2022,28(5):388–404
Lin Y, Liu M, Chen E, et al. Bone marrow-derived mesenchymal stem cells microvesicles stabilize atherosclerotic plaques by inhibiting NLRP3-mediated macrophage pyroptosis. Cell Biol Int, 2021,45(4):820–830
Gao H, Yu Z, Li Y, et al. miR-100-5p in human umbilical cord mesenchymal stem cell-derived exosomes mediates eosinophilic inflammation to alleviate atherosclerosis via the FZD5/Wnt/β-catenin pathway. Acta Biochim Biophys Sin (Shanghai), 2021,53(9):1166–1176
Ma J, Chen L, Zhu X, et al. Mesenchymal stem cell-derived exosomal miR-21a-5p promotes M2 macrophage polarization and reduces macrophage infiltration to attenuate atherosclerosis. Acta Biochim Biophys Sin (Shanghai), 2021,53(9):1227–1236
Yang W, Yin R, Zhu X, et al. Mesenchymal stem-cell-derived exosomal miR-145 inhibits atherosclerosis by targeting JAM-A. Mol Ther Nucleic Acids, 2021,23:119–131
Xiao X, Xu M, Yu H, et al. Mesenchymal stem cell-derived small extracellular vesicles mitigate oxidative stress-induced senescence in endothelial cells via regulation of miR-146a/Src. Signal Transduct Target Ther, 2021,6(1):354
Emini Veseli B, Perrotta P, De Meyer GRA, et al. Animal models of atherosclerosis. Eur J Pharmacol, 2017,816:3–13
Pan Q, Xu J, Wen CJ, et al. Nanoparticles: Promising Tools for the Treatment and Prevention of Myocardial Infarction. Int J Nanomedicine, 2021,16:6719–6747
Pechanova O, Barta A, Koneracka M, et al. Protective Effects of Nanoparticle-Loaded Aliskiren on Cardiovascular System in Spontaneously Hypertensive Rats. Molecules, 2019,24(15):2710
Yuan LF, Sheng J, Lu P, et al. Nanoparticle-mediated RNA interference of angiotensinogen decreases blood pressure and improves myocardial remodeling in spontaneously hypertensive rats. Mol Med Rep, 2015,12(3):4657–4663
Czyzynska-Cichon I, Janik-Hazuka M, Szafraniec-Szczęsny J, et al. Low Dose Curcumin Administered in Hyaluronic Acid-Based Nanocapsules Induces Hypotensive Effect in Hypertensive Rats. Int J Nanomedicine, 2021,16:1377–1390
Martín Giménez VM, Díaz-Rodríguez P, Sanz RL, et al. Anandamide-nanoformulation obtained by electrospraying for cardiovascular therapy. Int J Pharm, 2019,566:1–10
Jin Y, Song Y, Zhu X, et al. Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport. Biomaterials, 2012,33(5):1573–1582
Hasan AA, Madkor H, Wageh S. Formulation and evaluation of metformin hydrochloride-loaded niosomes as controlled release drug delivery system. Drug Deliv, 2013,20(3–4):120–126
Mao Y, Hu Y, Feng W, et al. Effects and mechanisms of PSS-loaded nanoparticles on coronary microcirculation dysfunction in streptozotocin-induced diabetic cardio-myopathy rats. Biomed Pharmacother, 2020,121:109280
Chen Y, Zeng Y, Zhu X, et al. Significant difference between sirolimus and paclitaxel nanoparticles in anti-proliferation effect in normoxia and hypoxia: The basis of better selection of atherosclerosis treatment. Bioact Mater, 2021,6(3):880–889
Ahn S, Lee IH, Lee E, et al. Oral delivery of an antidiabetic peptide drug via conjugation and complexation with low molecular weight chitosan. J Control Release, 2013,170(2):226–232
Boada C, Zinger A, Tsao C, et al. Rapamycin-Loaded Biomimetic Nanoparticles Reverse Vascular Inflammation. Circ Res, 2020,126(1):25–37
Ma S, Tian XY, Zhang Y, et al. E-selectin-targeting delivery of microRNAs by microparticles ameliorates endothelial inflammation and atherosclerosis. Sci Rep, 2016,6:22910
Seijkens TTP, van Tiel CM, Kusters PJH, et al. Targeting CD40-Induced TRAF6 Signaling in Macrophages Reduces Atherosclerosis. J Am Coll Cardiol, 2018,71(5):527–542
Ji J, Yang JA, He X, et al. Cardiac-targeting transfection of tissue-type plasminogen activator gene to prevent the graft thrombosis and vascular anastomotic restenosis after coronary bypass. Thromb Res, 2014,134(2):440–448
Pan H, Palekar RU, Hou KK, et al. Anti-JNK2 peptide-siRNA nanostructures improve plaque endothelium and reduce thrombotic risk in atherosclerotic mice. Int J Nanomedicine, 2018,13:5187–5205
Sager HB, Dutta P, Dahlman JE, et al. RNAi targeting multiple cell adhesion molecules reduces immune cell recruitment and vascular inflammation after myocardial infarction. Sci Transl Med, 2016,8(342):342ra80
Di Francesco V, Gurgone D, Palomba R, et al. Modulating Lipoprotein Transcellular Transport and Atherosclerotic Plaque Formation in ApoE(–/–) Mice via Nanoformulated Lipid-Methotrexate Conjugates. ACS Appl Mater Interfaces, 2020,12(34):37943–37956
Mishra S, Bedja D, Amuzie C, et al. Improved intervention of atherosclerosis and cardiac hypertrophy through biodegradable polymer-encapsulated delivery of glycosphingolipid inhibitor. Biomaterials, 2015,64:125–135
Barbieri LR, Lourenço-Filho DD, Tavares ER, et al. Influence of Drugs Carried in Lipid Nanoparticles in Coronary Disease of Rabbit Transplanted Heart. Ann Thorac Surg, 2017,104(2):577–583
Gomes FLT, Maranhão RC, Tavares ER, et al. Regression of Atherosclerotic Plaques of Cholesterol-Fed Rabbits by Combined Chemotherapy With Paclitaxel and Methotrexate Carried in Lipid Core Nanoparticles. J Cardiovasc Pharmacol Ther, 2018,23(6):561–569
Daminelli EN, Martinelli AE, Bulgarelli A, et al. Reduction of Atherosclerotic Lesions by the Chemotherapeutic Agent Carmustine Associated to Lipid Nanoparticles. Cardiovasc Drugs Ther, 2016,30(5):433–443
Ning B, Chen Y, Waqar AB, et al. Hypertension Enhances Advanced Atherosclerosis and Induces Cardiac Death in Watanabe Heritable Hyperlipidemic Rabbits. Am J Pathol, 2018,188(12):2936–2947
Mair KM, Robinson E, Kane KA, et al. Interaction between anandamide and sphingosine-1-phosphate in mediating vasorelaxation in rat coronary artery. Br J Pharmacol, 2010,161(1):176–192
Wu ZH, Ping QN, Wei Y, et al. Hypoglycemic efficacy of chitosan-coated insulin liposomes after oral administration in mice. Acta Pharmacol Sin, 2004,25(7):966–972
García-Díaz M, Foged C, Nielsen HM. Improved insulin loading in poly(lactic-co-glycolic) acid (PLGA) nanoparticles upon self-assembly with lipids. Int J Pharm, 2015,482(1–2):84–91
Luo XM, Yan C, Feng YM. Nanomedicine for the treatment of diabetes-associated cardiovascular diseases and fibrosis. Adv Drug Deliv Rev, 2021,172:234–248
Nakashiro S, Matoba T, Umezu R, et al. Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte/Macrophage Differentiation in ApoE–/–Mice. Arterioscler Thromb Vasc Biol, 2016,36(3):491–500
Aillon KL, Xie Y, El-Gendy N, et al. Effects of nanomaterial physicochemical properties on in vivo toxicity. Adv Drug Deliv Rev, 2009,61(6):457–466
Markovsky E, Baabur-Cohen H, Eldar-Boock A, et al. Administration, distribution, metabolism and elimination of polymer therapeutics. J Control Release, 2012, 161(2):446–460
Feng L, Yang X, Liang S, et al. Silica nanoparticles trigger the vascular endothelial dysfunction and prethrombotic state via miR-451 directly regulating the IL6R signaling pathway. Part Fibre Toxicol, 2019,16(1):16
Duan J, Yu Y, Yu Y, et al. Silica nanoparticles enhance autophagic activity, disturb endothelial cell homeostasis and impair angiogenesis. Part Fibre Toxicol, 2014,11:50
Duan J, Liang S, Yu Y, et al. Inflammation-coagulation response and thrombotic effects induced by silica nanoparticles in zebrafish embryos. Nanotoxicology, 2018,12(5):470–484
Maranhão RC, Guido MC, de Lima AD, et al. Methotrexate carried in lipid core nanoparticles reduces myocardial infarction size and improves cardiac function in rats. Int J Nanomedicine, 2017,12:3767–3784
Dong Z, Guo J, Xing X, et al. RGD modified and PEGylated lipid nanoparticles loaded with puerarin: Formulation, characterization and protective effects on acute myocardial ischemia model. Biomed Pharmacother, 2017,89:297–304
Nemmar A, Beegam S, Yuvaraju P, et al. Ultrasmall superparamagnetic iron oxide nanoparticles acutely promote thrombosis and cardiac oxidative stress and DNA damage in mice. Part Fibre Toxicol, 2016,13(1):22
El-Hussainy el HM, Hussein AM, Abdel-Aziz A, et al. Effects of aluminum oxide (Al2O3) nanoparticles on ECG, myocardial inflammatory cytokines, redox state, and connexin 43 and lipid profile in rats: possible cardioprotective effect of gallic acid. Can J Physiol Pharmacol, 2016,94(8):868–878
Guo B, Yang F, Zhang L, et al. Cuproptosis Induced by ROS Responsive Nanoparticles with Elesclomol and Copper Combined with aPD-Ll for Enhanced Cancer Immunotherapy. Adv Mater, 2023,35(22):e2212267
Chen W, Li D. Reactive Oxygen Species (ROS)-Responsive Nanomedicine for Solving Ischemia-Reperfusion Injury. Front Chem, 2020,8:732
Deng Z, Liu S. Inflammation-responsive delivery systems for the treatment of chronic inflammatory diseases. Drug Deliv Transl Res, 2021,11(4):1475–1497
Hu S, Wang X, Li Z, et al. Platelet membrane and stem cell exosome hybrid enhances cellular uptake and targeting to heart injury. Nano Today, 2021,39:101210
Liang D, Feng Y, Zandkarimi F, et al. Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones. Cell, 2023,86(13):2748–2764.e22
Yalcinkaya M, Fotakis P, Liu W, et al. Cholesterol accumulation in macrophages drives NETosis in atherosclerotic plaques via IL-lβ secretion. Cardiovasc Res, 2023,119(4):969–981
Libby P. The changing landscape of atherosclerosis. Nature, 2021,592(7855):524–533
van Hasselt JGC, Iyengar R. Systems Pharmacology: Defining the Interactions of Drug Combinations. Annu Rev Pharmacol Toxicol, 2019,59:21–40
Gupta V, Datta P. Next-generation strategy for treating drug resistant bacteria: Antibiotic hybrids. Indian J Med Res, 2019,149(2):97–106
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Additional information
This work was supported by the National Natural Science Foundation of China (No. 81573957, No. 81874461 and No. 82070307).
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License https://creativecommons.org/licenses/by/4.0/), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Pan, Q., Chen, C. & Yang, Yj. Top Five Stories of the Cellular Landscape and Therapies of Atherosclerosis: Current Knowledge and Future Perspectives. CURR MED SCI 44, 1–27 (2024). https://doi.org/10.1007/s11596-023-2818-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11596-023-2818-2